VENLO, The Netherlands, Oct. 30 In conjunctionwith QIAGEN's Third Quarter 2007 Earnings release, you are invited to listento its conference call which will be broadcast live over the Internet onTuesday, November 6, 2007 at 9:30 a.m. EST, with Peer M. Schatz, President andChief Executive Officer and Roland Sackers, Chief Financial Officer.
QIAGEN N.V., a Netherlands holding company, is a leading provider ofinnovative technologies and products for pre-analytical sample preparation andmolecular diagnostics solutions. QIAGEN has developed a comprehensiveportfolio of more than 500 proprietary, consumable products and automatedsolutions for sample collection, and nucleic acid and protein handling,separation, and purification. QIAGEN also supplies diagnostic kits, tests, andassays for human and veterinary molecular diagnostics. The company's productsare sold to academic research markets, and to leading pharmaceutical andbiotechnology companies; as well as to diagnostics laboratories. QIAGEN alsoprovides purification and testing solutions to applied testing markets: suchas forensics, animal or food testing, and pharmaceutical process control.
QIAGEN employs more than 2,600 people worldwide. QIAGEN products are soldthrough a dedicated sales force and a global network of distributors in morethan 40 countries.
Further information about QIAGEN can be found at www.qiagen.com.
(Minimum Requirements to listen to broadcast: The RealPlayer software,downloadable free from http://www.real.com/products/player/index.html, or TheWindows Media Player, downloadable free from www.microsoft.com and at least a14.4Kbps connection to the Internet. If you experience problems listening tothe broadcast, send an email to [email protected]
)What: QIAGEN N.V. -- Third Quarter 2007 Earnings Announcement When: Tuesday, November 6, 2007 at 9:30 a.m. EST Where: http://www.QIAGEN.com/goto/061107 How: Live over the Internet -- Simply log on to the Web at the address above. The corresponding presentation slides are available to download in the investor relations section of QIAGEN's website at: www.QIAGEN.com/goto/061107 Contact: Andreas Marathovouniotis, Russo Partners, 212-845-4253
SOURCE QIAGEN N.V.